Showing results (491-500 of 2,280) with videos related to
Sort By:
Pageof 228
HIV Medicine|June 10, 2020
Potentially inappropriate medications in older adults living with HIVB López-Centeno, C Badenes-Olmedo, A Mataix-Sanjuan, et al.HIV Medicine|July 4, 2025
Retention outcomes during same-day antiretroviral therapy initiation in health facilities and outreach settings of Rakai, Uganda, 2016-2021Jesca Basiima, Victor Ssempijja, Anthony Ndyanabo, et al.HIV Medicine|July 2, 2025
False-positive reactivity of fourth-generation HIV enzyme immunoassay caused by COVID-19 and other infectionsHaidi Karam-Allah Ramadan, Ahmed Elhussiny Salah, Zeinab R Mohamed, et al.HIV Medicine|December 6, 2025
Assessing cancer-related mortality risk among people with HIV in Vietnam: A nationwide population studyNgoan Tran Le, Ngan Dieu-Thi Ta, Thao Thi-Thu Vu, et al.HIV Medicine|February 13, 2025
Weight and mortality in people living with HIV and heart failure: Obesity paradox in the era of glucagon-like peptide 1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitorsNatalia Nazarenko, Yi-Yun Chen, Pawel Borkowski, et al.HIV Medicine|December 20, 2024
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY studyHajra Okhai, Alan Winston, Frank Post, et al.HIV Medicine|February 5, 2025
Impact of HBV serological status on HIV virological efficacy of two-drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravirPierluigi Francesco Salvo, Arturo Ciccullo, Elena Visconti, et al.HIV Medicine|February 24, 2025
HIV in Latin American migrants in the UK: A neglected population in the 95-95-95 targetsNatalie Elkheir, Catherine Dominic, Amy Price, et al.HIV Medicine|February 20, 2025
Associations between country of birth, migration status and engagement in HIV care among gay and bisexual men living with HIV in Australia, 2019-2022Simin Yu, James MacGibbon, Benjamin Bavinton, et al.HIV Medicine|January 24, 2025
A programmatic assessment of dolutegravir adverse events and discontinuations in UgandaEva Agnes Laker Odongpiny, Melanie Nicol, Elizabeth Katana, et al.Pageof 228